Yes. Kevin Hern disclosed 2 sales of Novo Nordisk A S (NVO) stock between Aug 31, 2026 and Sep 10, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.
Yes. Kevin Hern disclosed 2 sales of Novo Nordisk A S (NVO) stock between Aug 31, 2026 and Sep 10, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.
How big were Kevin Hern's Novo Nordisk A S trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.
Did Kevin Hern make these Novo Nordisk A S trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Kevin Hern still own Novo Nordisk A S stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Kevin Hern report these trades?
The latest filing is dated Sep 25, 2026. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.
Loading